As one of the Leeds ECMC team’s most established figure-heads, Professor Phil Quirke runs an active research group in bowel cancer as well as being the Academic Training Programme Director for West Yorkshire and the Chair of the NHS Bowel Cancer Screening Programme Pathology Committee.
The ECMC were sad to say goodbye to Elliann Fairbairn, who finished her hugely successful time in the Secretariat to begin a new adventure in Canada. However, we are thrilled to announce that Ilaria Mirabile has decided to join us as the new ECMC Network Insight Project Manager.
Ilaria joins us from the Stratified Medicine team, where she worked for 2 years. She brings her notable experience with working with the early-phase clinical centres to her new role within the ECMC team.
Last month we said farewell to Brian Sheehan, who after five years with Cancer Research UK and several months as Head of the ECMC Secretariat, parted company to return to Cambridge to take up an exciting opportunity with a pharmaceutical company called Mundipharma.
However in his place, our team are delighted in welcoming Steve Nabarro to fill in the post as interim Head of the ECMC Secretariat.
The ECMC network strives to enhance communication between UK centres so that expertise can be shared and synergized. Nuria Vazquez Salat, Senior Research Manager of the ECMC Secretariat, won a Cancer Research UK (CRUK) Foulkes’ Fellowship to find out how our French and German counterparts match the UK’s approach.
Theatre nurse, Lyn Barrington, also a former colorectal nurse specialist, opened this year’s Annual Network Meeting by describing her experiences of being diagnosed with lung cancer and of her journey to being accepted on an immunotherapy trial.
We spoke to Lyn and you can read the interview in full below. With many thanks to Lyn for all her time, commitment and honesty.
It took two years for your cancer to be diagnosed. Why did it take so long?
Aoife Regan has recently taken over as head of the ECMC Secretariat; here we learn a little bit more about her.
Communicating about research and particularly about early phase trials with patients and public is a challenge all ECMCs face.